Meeting Report: FIP/AAPS Joint Workshop Report: Dissolution/In Vitro Release Testing of Novel/Special Dosage Forms
نویسندگان
چکیده
In 2003, the FIP Dissolution Working group published a position paper on dissolution/drug release testing for special/novel dosage forms that represented the scientific opinions of many experts in the field at that time (1). The position paper has supported activities, programs, and decisions in the scientific, technical, and regulatory community. Due to the rapid evolution of new practices and techniques for in vitro testing, the FIP Special Interest Group (SIG) on Dissolution/Drug Release decided to revise the previous paper and added proposals for further harmonization of in vitro release testing practices for different pharmaceutical dosage forms. This article represents the current updates to the previously published paper. This revision has been aligned to coincide with the USP taxonomy including route of administration, intended site of drug release, and dosage form. The revised paper includes information from current literature, expert discussions, and presentations from recent workshops (2,3). The authors
منابع مشابه
Workshop Summary: AAPS Workshop on Special Dosage Forms—What’s New with In Vitro Drug Release?
International Perspectives on the Drug Release of Special Dosage Forms This workshop was co-sponsored by FDA and FIP. This kick-off presentation introduced the workshop by providing background and objectives. The workshop focused on modified-release drug forms and included regulatory perspectives and specific presentations for orally disintegrating tablets, chewable oral drug products, ophthalm...
متن کاملMeeting Report: AAPS Workshop on Oral Bioperformance and 21st Century Testing
The AAPS Workshop on Oral Bioperformance and 21st Century Testing was held in Chicago, Illinois, on October 13 and 14, 2012. The main objective of the workshop was to reevaluate and discuss the use of dissolution testing in a more biorelevant scenario. When dissolution testing was introduced in the early 1970s, there was a debate whether the test should be a development or a quality control too...
متن کاملAAPS Workshop: accelerating pharmaceutical development through predictive stability approaches, April 4–5, 2016
There has been significant growth in the use of modeling tools to accelerate development and enhance pharmaceutical quality. Among these are empirical and semi-empirical modeling of accelerated stability studies which can be used to predict product shelf-life (Waterman, Pharm Res 24:780–790, 2007; (Wu et al., AAPS Pharm Sci Tech,16:986–991, 2016); (Lavrich, Rapid Development of Robust Stability...
متن کاملAAPS Workshop on the Role of Dissolution in QbD and Drug Product Life Cycle: A Commentary
This is a summary report of the “AAPS Workshop on the Role of Dissolution in QbD and Drug Product Life Cycle” organized by the AAPS In Vitro Release and Dissolution Testing (IVDRT) Focus Group. Representatives from the pharmaceutical industry, regulatory authorities, and academia in the U.S. and Europe attended this workshop to discuss the role of dissolution in a Quality by Design (QbD) settin...
متن کاملCloudy with a Chance of Precipitation: Novel in Vitro
AAPS held its Annual Meeting and Exposition at the Convention Center in San Diego, California, during the week of November 2–6, 2014. The meeting is a premier gathering of pharmaceutical scientists from around the world and works to address the needs of the attendees, including members of over 40 Focus Groups in nine Sections, or scientific disciplines, including two focused on dissolution test...
متن کامل